St. Jude Medical Inc. (NYSE: STJ) has settled a royalty dispute with medical device maker Kensey Nash Corp. (NASDAQ: KNSY) over a device that St. Jude licensed from Kensey in 1999. The settlement amount is $39 million to be paid to Kensey in 12 quarterly installments beginning March 31st.
Shares in St. Jude Medical are down about -1% at $42.42 in a 52-week range of $32.13-$54.18. Kensey Nash shares are up more than 21% at $29.80 after posting a new 52-week high of $30.39 earlier this morning.
Paul Ausick has been writing for a673b.bigscoots-temp.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.
Our top personal finance-related articles today. Your wallet will thank you later.
Top Gaining Stocks
Top Losing Stocks